Every day at the Penn Memory Center, we hear caregivers describe the emotional, physical, and logistical challenges they face tending to their loved ones. We’re here to help.
Through the Empowering Caregivers series, caregivers will have access to area experts who will present on a variety of intensive topics from symptom management to end-of-life care.
Winter/Spring 2026 Schedule
April 24 at noon via Zoom
Anti-amyloid Therapies: An Update
Join Penn Memory Center Co-Director Dr. David Wolk for an updated overview of the disease-modifying therapies available to people in the early stages of Alzheimer’s Disease. In addition to an explanation of available treatments, how they work, and who they are appropriate for, Dr. Wolk will provide an overview of how he as a clinician helps patients and families navigate the decision-making that goes into whether or not to take them.
About the speaker:
David Wolk, MD, is a professor of Neurology, chief of the division of Cognitive Neurology, director of the National Institute of Aging funded Penn Alzheimer’s Disease Research Center, co-director of the Penn Institute on Aging, and co-director of the Penn Memory Center.
Dr. Wolk’s primary clinical interest has been in the diagnosis and care of individuals with a variety of neurodegenerative conditions. His research has focused on the cognitive neuroscience of memory decline associated with aging and Alzheimer’s Disease using techniques including behavioral testing, structural and functional MRI, and FDG and molecular PET imaging. Much of this work is also directed at examining biomarkers, including behavioral and neuroimaging, that differentiate healthy aging from the earliest transition to AD and their potential role in understanding disease mechanisms and incorporation into treatment trials. Another related thread of his work has been to better understand, classify and predict sources of heterogeneity in AD. Dr. Wolk has had sustained NIH support since 2003 and has been the principal or co-investigator on numerous local, national and international studies, including therapeutic trials.
Register here